Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

421 articles

Keyword: Cancer treatmentClear keyword

Materials today. Bio2026ReviewDrug Delivery

1. Magnetic nanorobots in oncology: From targeted drug delivery to smart theranostic systems

Liu X, Li C, Xu Z, Yan Y, Liu W, Li Y, Et Al.

This review focuses on the application of magnetic nanorobots (MNRs) in tumor therapy. We first introduce the MNR-mediated drug delivery strategy, which loads anti-tumor agents and actively targets tumor sites. Leveraging the unique physicochemical properties of their constituent materials, MNRs enable controlled drug release in response to specific internal or external stimuli.

Cancer treatment Drug resistance Magnetic nanorobots Nanomaterials Tumor microenvironments

Read the article

International journal of nanomedicine2026ReviewDrug Delivery

2. Organelle-Targeted Nanocarriers for Cancer Therapy: Design Principles, Intracellular Trafficking, and Translational Barriers in Precision Drug Delivery

Zhang H, Guo J, Wang X, Shen Y, Yao Y, Ghadage Ss, Et Al.

The clinical translation of cancer nanomedicine remains constrained by inefficient intracellular delivery, poor subcellular specificity, and limited tumor accumulation, highlighting the need for more precise drug delivery strategies. Organelle-targeted nanocarriers have emerged as a promising platform for enhancing therapeutic efficacy by directing drugs to specific intracellular compartments, including the nucleus, mitochondria, lysosomes, and endoplasmic reticulum.

cancer treatment endoplasmic reticulum golgi apparatus lysosome nano-drugs organelle-targeted mitochondrion therapy organelle-targeted nucleus therapy

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through GMP supply.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes, licensing and GMP supply.InvestorsDownload our capabilities deckPlatform, pipeline milestones, manufacturing and partnership models in one PDF.